Tuesday, June 16, 2026

Kim Jong Un Unveils Renovated Workers’ Resort: A Step Toward Modernization in North Korea?

Kim Jong Un attended the opening of the Onpo Workers' Rest Home, praising renovations and promoting industrial development in North Korea.

North Korea Reports Mining, Chemical, and Agricultural Gains as Workers’ Party Marks 80 Years

North Korea celebrates the Workers' Party's 80th anniversary with economic achievements, loyalty letters, and cultural activities for seniors.

Kim Jong Un Mobilizes Youth for Major Flood Recovery Mission

According to the latest local report, party members and youth volunteers have arrived in the affected areas to begin the work.

Tag: CAR-T therapy

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

Revolutionary CAR-T Treatment SynKIR-310 Outperforms CD19 CAR-T: What This Means for Blood Cancer Patients

Verismo Therapeutics' SynKIR-310 shows superior anti-tumor effects in preclinical studies, promising a safer CAR-T therapy for blood cancers.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us